RNA aptamer therapy for vaso-occlusion in sickle cell disease

Nucleic Acid Therapeutics

Volumn 21, Issue 4, 2011, Pages 275-283

  Burnette, Angela D ^a   Nimjee, Shahid M ^a   Batchvarova, Milena ^a   Zennadi, Rahima ^a   Telen, Marilyn J ^a   Nishimura, Jun Ichi ^b   Sullenger, Bruce A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; COMPLEMENT; HEPARIN; INTERLEUKIN 13; PADGEM PROTEIN; PF 377; RNA; THROMBIN; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; BLOOD VESSEL OCCLUSION; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RNA APTAMER THERAPY; RNA BINDING; SHEAR STRESS; SICKLE CELL; SICKLE CELL ANEMIA; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; APTAMERS, NUCLEOTIDE; CELL ADHESION; CELLS, CULTURED; ERYTHROCYTES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTEGRIN ALPHAVBETA3; P-SELECTIN;

EID: 80052212721     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2010.0270     Document Type: Article

References (38)

1. BIESECKER, G., DIHEL, L., ENNEY, K., and BENDELE, R.A. (1999). Derivation of RNA aptamer inhibitors of human complement C5. Immunopharmacology 42, 219-230. (Pubitemid 29322305)
2. BRITTAIN, H.A., ECKMAN, J.R., SWERLICK, R.A., HOWARD, R.J., and WICK, T.M. (1993). Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood 81, 2137-2143. (Pubitemid 23106730)
3. BRITTAIN, J.E., MLINAR, K.J., ANDERSON, C.S., ORRINGER, E.P., and PARISE, L.V. (2001). Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction. J. Clin. Invest. 107, 1555-1562. (Pubitemid 32577083)
4. BYZOVA, T.V., and PLOW, E.F. (1998). Activation of al-phaVbeta3 on vascular cells controls recognition of pro-thrombin. J. Cell. Biol. 143, 2081-2092. (Pubitemid 29022626)
5. CHEUNG, A.T., HARMATZ, P., WUN, T., CHEN, P.C., LAR-KIN, E.C., ADAMS, R.J., and VICHINSKY, E.P. (2001). Correlation of abnormal intracranial vessel velocity, measured by transcranial Doppler ultrasonography, with abnormal con-junctival vessel velocity, measured by computer-assisted in-travital microscopy, in sickle cell disease. Blood 97, 3401-3404.
6. COLLER, B.S. (2001). Anti-GPIIb/IIIa drugs: current strategies and future directions. Thromb. Haemost. 86, 427-443. (Pubitemid 32663972)
7. DAS, S.K., HINDS, J.E., HARDY, R.E., COLLINS, J.C., and MUKHERJEE, S. (1993). Effects of physical stress on peroxide scavengers in normal and sickle cell trait erythrocytes. Free Radic. Biol. Med. 14, 139-147. (Pubitemid 23037069)
8. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
9. EMBURY, S.H., MATSUI, N.M., RAMANUJAM, S., MAYADAS, T.N., NOGUCHI, C.T., DIWAN, B.A., MOHANDAS, N., and CHEUNG, A.T. (2004). The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythro-cytes in vivo. Blood 104, 3378-3385. (Pubitemid 39507162)
10. FINNEGAN, E.M., BARABINO, G.A., LIU, X.D., CHANG, H.Y., JONCZYK, A., and KAUL, D.K. (2007). Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion. Am. J. Physiol. Heart Circ. Physiol. 293, H1038-H1045. (Pubitemid 47254203)
11. FRENETTE, P.S. (2002). Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr. Opin. Hematol. 9, 101-106. (Pubitemid 34171484)
12. GIL, K.M., CARSON, J.W., PORTER, L.S., SCIPIO, C., BE-DIAKO, S.M., and ORRINGER, E. (2004). Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle-cell disease. Health Psychol. 23, 267-274. (Pubitemid 38542358)
13. HAILER, N.P., OPPERMANN, E., LECKEL, K., CINATL, J., MARKUS, B.H., and BLAHET, A.R.A. (2000). Prostaglandin E2 induces expression of P-selectin (CD62P) on cultured human umbilical vein endothelial cells and enhances endothelial binding of CD4-T-cells. Transplantation 70, 236-240. (Pubitemid 30490790)
14. HARLAN, J.M. (2000). Introduction: anti-adhesion therapy in sickle cell disease. Blood 95, 365-367. (Pubitemid 30041642)
15. HEBBEL, R.P. (2000). Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies. N. Engl. J. Med. 342, 1910-1912. (Pubitemid 30419059)
16. HINES, P.C., ZEN, Q., BURNEY, S.N., SHEA, D.A., ATAGA, K.I., ORRINGER, E.P., TELEN, M.J., and PARISE, L.V. (2003). Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion. Blood 101, 3281-3287. (Pubitemid 36858025)
17. JACKSON, S.P., and SCHOENWAELDER, S.M. (2003). Anti-platelet therapy: in search of the magic bullet'. Nat. Rev. Drug Discov. 2, 775-789.
18. JENISON, R.D., JENNINGS, S.D., WALKER, D.W., BARGATZE, R.F., and PARMA, D. (1998). Oligonucleotide inhibitors of P-selectin-dependent neutrophil-platelet adhesion. Antisense Nucleic Acid Drug Dev. 8, 265-279. (Pubitemid 28446114)
19. KAUL, D.K., and FABRY, M.E. (2004). In vivo studies of sickle red blood cells. Microcirculation 11, 153-165. (Pubitemid 39619076)
20. KAUL, D.K., TSAI, H.M., LIU, X.D., NAKADA, M.T., NAGEL, R.L., and COLLER, B.S. (2000). Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood 95, 368-374. (Pubitemid 30041643)
21. MALEK, A.M., ALPER, S.L., and IZUMO, S. (1999). Hemody-namic shear stress and its role in atherosclerosis. JAMA 282, 2035-2042.
22. MATSUI, N.M., VARKI, A., and EMBURY, S.H. (2002). Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin. Blood 100, 3790-3796. (Pubitemid 35303953)
23. MI, J., ZHANG, X., GIANGRANDE, P.H., MCNAMARA, J.O., NIMJEE, S.M., SARRAF-YAZDI, S., SULLENGER, B.A., and CLARY, B.M. (2005). Targeted inhibition of alphavbeta3 in-tegrin with an RNA aptamer impairs endothelial cell growth and survival. Biochem. Biophys. Res. Commun. 338, 956-963. (Pubitemid 41597735)
24. NIMJEE, S.M., RUSCONI, C.P., and SULLENGER, B.A. (2005). Aptamers: an emerging class of therapeutics. Annu. Rev. Med. 56, 555-583. (Pubitemid 40299797)
25. RONDAIJ, M.G., BIERINGS, R., KRAGT, A., VAN MOURIK, J.A., and VOORBERG, J. (2006). Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26, 1002-1007. (Pubitemid 43732104)
26. SETTY, B.N., KULKARNI, S., and STUART, M.J. (2002). Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood 99, 1564-1571. (Pubitemid 34533027)
27. STUART, M.J., and NAGEL, R.L. (2004). Sickle-cell disease. Lancet 364, 1343-1360. (Pubitemid 39335827)
28. SWERLICK, R.A., ECKMAN, J.R., KUMAR, A., JEITLER, M., and WICK, T.M. (1993). Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 82, 1891-1899. (Pubitemid 23278781)
29. TELEN, M.J. (2000). Red blood cell surface adhesion molecules: their possible roles in normal human physiology and disease. Semin. Hematol. 37, 130-142. (Pubitemid 30211152)
30. TELEN, M.J. (2007). Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease. He-matol. Am. Soc. Hematol. Educ. Program. 2007, 84-90.
31. THOMAS, V.J., HAMBLETON, I., and SERJEANT, G. (2001). Psychological distress and coping in sickle cell disease: comparison of British and Jamaican attitudes. Ethn. Health 6, 129-136. (Pubitemid 32656481)
32. TUERK, C., and GOLD, L. (1990). Systematic evolution of li-gands by exponential enrichment: RNA ligands to bacterio-phage T4 DNA polymerase. Science 249, 505-510.
33. UDANI, M., ZEN, Q., COTTMAN, M., LEONARD, N., JEFFERSON, S., DAYMONT, C., TRUSKEY, G., and TELEN, M.J. (1998). Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin. J. Clin. Invest. 101, 2550-2558. (Pubitemid 28270449)
34. UNTHANK, J.L., LASH, J.M., NIXON, J.C., SIDNER, R.A., and BOHLEN, H.G. (1993). Evaluation of carbocyanine-labeled erythrocytes for microvascular measurements. Microvasc. Res. 45, 193-210.
35. USHIYAMA, S., LAUE, T.M., MOORE, K.L., ERICKSON, H.P., and MCEVER, R.P. (1993). Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin. J. Biol. Chem. 268, 15229-15237. (Pubitemid 23206679)
36. WOLTMANN, G., MCNULTY, C.A., DEWSON, G., SYMON, F.A., and WARDLAW, A.J. (2000). Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood 95, 3146-3152. (Pubitemid 30321166)
37. XIAO, Y., and TRUSKEY, G.A. (1996). Effect of receptor-ligand affinity on the strength of endothelial cell adhesion. Biophys. J. 71, 2869-2884. (Pubitemid 26367749)
38. ZENNADI, R., HINES, P.C., DE CASTRO, L.M., CARTRON, J.P., PARISE, L.V., and TELEN, M.J. (2004). Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions. Blood 104, 3774-3781. (Pubitemid 39564457)